Report Detail

Medical Devices & Consumables Medical Device Contract Manufacturing Global Market - Forecast to 2026

  • RnM3925071
  • |
  • 12 March, 2020
  • |
  • Global
  • |
  • 381 Pages
  • |
  • IQ4I Research & Consultancy
  • |
  • Medical Devices & Consumables

Medical device contract manufacturing is a business model in which a medical device company outsources certain or the whole production activities of their whole medical device or certain components of the device to another company with specialized knowledge, technical expertise and efficient business operations. The services offered by the medical device contract manufacturers (MDCMs) consist of product design and development, product manufacturing and assembly, quality testing services, packaging and sterilization services and regulatory consulting services. Today’s contract manufacturers, in response to the rapidly growing and evolving medical device industry, have broadened their manufacturing capabilities, technological expertise and business definitions to transform themselves into ‘total solutions provider’ or ‘full-service provider’ or ‘end to end solution provider’ or ‘one-stop shopping destination’. Increasing pressure of healthcare cost curbs on medical device companies, the need to reduce time to market, to manufacture competitively advantageous and distinct products at a reduced cost, to streamline in-house processes and focus more on critical business areas or competencies and gaining access to advanced technologies are fuelling the growth in medical device contract manufacturing market.
As estimated by IQ4I Research, the medical device contract manufacturing global market is expected to reach $97,239.4 million by 2026 growing at a high single digit CAGR from 2019 to 2026 due to increasing prevalence of chronic and infectious diseases, advanced manufacturing capabilities of contract manufacturers, rapidly increasing geriatric population, favorable reimbursement scenario in major markets, technological innovations in medical devices, increase in the number of surgical procedures and hospitalizations, ever-changing regulatory landscape, growing economies and increasing demand for better healthcare facilities in emerging markets. The medical device contract manufacturing market is segmented by device type, service, product, application and geography.
Based on the device type, the medical device contract manufacturing global market is segmented into Electronic Medical Device Contract Manufacturing and Non-Electronic Medical Device Contract Manufacturing. Electronic Medical Device Contract Manufacturing segment accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026. Non-Electronic Medical Device Contract Manufacturing segment is expected to grow at a mid single digit CAGR from 2019 to 2026.
Based on the service type, the medical device contract manufacturing global market is segmented into Product Design and Development service, Product Manufacturing and Assembly service, Quality Testing service, Packaging & Sterilization service and Regulatory Consulting service. Among these services, Product Manufacturing and Assembly service is the largest and fastest growing service segment. It accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.
Based on the product type, the medical device contract manufacturing global market is segmented into Diagnostic and Monitoring Devices, Therapeutic Devices, Drug Delivery Devices and Others (Surgical devices and tools). Among these products, Therapeutic Devices holds the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.
Based on the application, the medical device contract manufacturing global market is segmented into Cardiology, Diagnostic Imaging, Orthopedic, Endoscopy, Dental, Diabetes Care, Wound Management, Nephrology, in-vitro diagnostics (IVD), Respiratory and others (Surgical devices and tools). Among these, the in-vitro diagnostics (IVD) segment accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026. Cardiology is the fastest growing application segment in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026 due to increasing cardiovascular disease burden throughout the world.
Based on the region, the medical device contract manufacturing global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). North America accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026 due to increasing prevalence of chronic and lifestyle diseases there, huge investments and researches in the medical device field, increasing demand for technologically advanced innovative healthcare devices, increasing healthcare expenditure, increasing investments on sophisticated infrastructures and enhanced manufacturing capabilities of the contract manufacturers and availability of a large pool of technical expertise.
The Asia-Pacific is the fastest growing region in medical device contract manufacturing market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026 due to increasing incidence of chronic and infectious diseases, increasing income and affordability of the population, increasing healthcare awareness and public spending in healthcare, increasing private investment in healthcare sector, increasing penetration of health insurance schemes, innovations promoted by public-private partnership (PPP), high geriatric population, government initiatives for the promotion of medical device industry, increase in the number of surgeries and hospitalizations, growing demand for better healthcare facilities, increasing adoption of implantable devices, high acceptance of technological advancements, huge manufacturing facilities and low-cost labor.
The medical device contract manufacturing global market is highly fragmented without a dominant major player in the market that offers huge opportunities for small and medium-sized companies with distinct products or services in the market. The top ten players occupy minimum market share and the majority of the market is occupied by other players. Some of the major players in medical device contract manufacturing market include Flex (Singapore), Jabil (U.S.), Integer Holdings (U.S.), Celestica (Canada), Sanmina (U.S.), Plexus (U.S.), Gerresheimer (Germany), Molex (U.S.), Tecomet (U.S.), West Pharmaceuticals (U.S), Benchmark Electronics (U.S.), Orchid Orthopedic Solutions (U.S.) and TE Connectivity (Switzerland).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o U.K.
o France
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East & Africa


1 EXECUTIVE SUMMARY 22

    2 INTRODUCTION 28

    • 2.1 KEY TAKEAWAYS 28
    • 2.2 SCOPE OF THE REPORT 29
    • 2.3 REPORT DESCRIPTION 29
    • 2.4 MARKETS COVERED 32
    • 2.5 STAKEHOLDERS 34
    • 2.6 RESEARCH METHODOLOGY 34
      • 2.6.1 MARKET SIZE ESTIMATION 35
      • 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 38
      • 2.6.3 SECONDARY SOURCES 39
      • 2.6.4 PRIMARY SOURCES 40
      • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 40
      • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 41
      • 2.6.7 ASSUMPTIONS 41

    3 MARKET ANALYSIS 43

    • 3.1 INTRODUCTION 43
    • 3.2 MARKET SEGMENTATION 44
    • 3.3 FACTORS INFLUENCING MARKET 46
      • 3.3.1 DRIVERS AND OPPORTUNITIES 47
        • 3.3.1.1 Increasing trend of outsourcing 47
        • 3.3.1.2 Advanced manufacturing capabilities 48
        • 3.3.1.3 Increase in surgeries and hospitalizations 49
        • 3.3.1.4 High prevalence of chronic and infectious diseases 50
        • 3.3.1.5 Technological advancements in medical devices 51
        • 3.3.1.6 Rapidly aging worldwide population 52
        • 3.3.1.7 Increasing trend of consolidation 52
      • 3.3.2 RESTRAINTS AND THREATS 53
        • 3.3.2.1 Lack of competency to develop class III devices 53
        • 3.3.2.2 Lack of skilled technicians 54
        • 3.3.2.3 Medical device product recalls due to FDA mandates 54
        • 3.3.2.4 Advancements in pharmaceuticals drugs 56
        • 3.3.2.5 Stringent regulatory guidelines 56
    • 3.4 REGULATORY AFFAIRS 57
      • 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 57
        • 3.4.1.1 ISO 9001: 2015 quality management system 58
        • 3.4.1.2 ISO 13485 medical devices 58
        • 3.4.1.3 ISO 10993 biological evaluation of medical devices 58
        • 3.4.1.4 ISO 14971: risk management of medical devices 59
        • 3.4.1.5 ISO 13482:2014 safety requirements for personal care robots 59
        • 3.4.1.6 IEC 60601-1 medical electrical equipment standard 59
        • 3.4.1.7 IEC 60601-1-2 electromagnetic compatibility (EMC) for medical devices 60
        • 3.4.1.8 IEC 60601-1-11 home care safety 60
        • 3.4.1.9 IEC 62304:2006- software life cycle 60
      • 3.4.2 U.S. 60
      • 3.4.3 CANADA 61
      • 3.4.4 EUROPE 62
      • 3.4.5 JAPAN 63
      • 3.4.6 CHINA 64
      • 3.4.7 INDIA 65
    • 3.5 TECHNOLOGICAL ADVANCEMENTS 66
      • 3.5.1 ADDITIVE MANUFACTURING OR 3D PRINTING 67
      • 3.5.2 LASER AND MICRO WELDING 67
      • 3.5.3 PLASMA TREATMENT 67
      • 3.5.4 EXTRUSION 68
      • 3.5.5 AUTOMATION 68
      • 3.5.6 MICRO INJECTION MOLDING OR MICRO MOLDING 69
    • 3.6 PORTER’S FIVE FORCE ANALYSIS 70
      • 3.6.1 THREAT OF NEW ENTRANTS 71
      • 3.6.2 THREAT OF SUBSTITUTES 71
      • 3.6.3 BARGAINING POWER OF SUPPLIERS 72
      • 3.6.4 BARGAINING POWER OF BUYERS 72
      • 3.6.5 COMPETITIVE RIVALRY 72
    • 3.7 SUPPLY CHAIN ANALYSIS 74
    • 3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 78
      • 3.8.1 MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET SHARE ANALYSIS 78
      • 3.8.2 ORTHOPEDIC MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET SHARE ANALYSIS 81
    • 3.9 MARKET PENETRATION 84
    • 3.10 ANALYSIS OF HIGH PROFIT MEDICAL DEVICES 87
    • 3.11 CHINA V/S INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 89
      • 3.11.1 INDIA 89
      • 3.11.2 CHINA 91
    • 3.12 FDA APPROVED MEDICAL DEVICE CONTRACT MANUFACTURING FACILITIES 92
    • 3.13 MEDICAL DEVICES APPROVAL BY U.S. FDA 94
    • 3.14 GLOBAL MAJOR MEDICAL DEVICE NUMBER OF UNITS 95
    • 3.15 MDCM COMPANY COMPARISON TABLE BY REVENUE, PRODUCTS, SERVICES AND APPLICATIONS 97

    4 MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET, BY DEVICE TYPE 105

    • 4.1 INTRODUCTION 105
    • 4.2 ELECTRONIC MEDICAL DEVICE CONTRACT MANUFACTURING 111
    • 4.3 NON-ELECTRONIC MEDICAL DEVICE CONTRACT MANUFACTURING 113

    5 MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET, BY SERVICE 116

    • 5.1 INTRODUCTION 116
    • 5.2 PRODUCT DESIGN AND DEVELOPMENT SERVICES 119
    • 5.3 PRODUCT MANUFACTURING AND ASSEMBLY SERVICES 122
    • 5.4 QUALITY SERVICES 126
    • 5.5 REGULATORY CONSULTING SERVICES 129
    • 5.6 PACKAGING & STERILIZATION SERVICES 131

    6 MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET, BY PRODUCT 135

    • 6.1 INTRODUCTION 135
    • 6.2 DIAGNOSTIC AND MONITORING DEVICES 138
    • 6.3 THERAPEUTIC DEVICES 142
    • 6.4 DRUG DELIVERY DEVICES 146
    • 6.5 OTHERS 149

    7 MEDICAL DEVICE CONTRACT MANUFACTURING GLOBAL MARKET, BY APPLICATION 154

    • 7.1 INTRODUCTION 154
    • 7.2 CARDIOLOGY 157
    • 7.3 DIAGNOSTIC IMAGING 160
    • 7.4 ORTHOPEDIC 162
    • 7.5 ENDOSCOPY 165
    • 7.6 DENTAL 167
    • 7.7 DIABETES CARE 170
    • 7.8 WOUND MANAGEMENT 173
    • 7.9 NEPHROLOGY 176
    • 7.10 IN-VITRO DIAGNOSTICS 179
    • 7.11 RESPIRATORY 182
    • 7.12 OTHER APPLICATIONS 185

    8 REGIONAL ANALYSIS 189

    • 8.1 INTRODUCTION 189
    • 8.2 NORTH AMERICA 194
      • 8.2.1 U.S. 204
      • 8.2.2 REST OF NORTH AMERICA 209
    • 8.3 EUROPE 214
      • 8.3.1 GERMANY 223
      • 8.3.2 U.K. 227
      • 8.3.3 FRANCE 231
      • 8.3.4 REST OF EUROPE 235
    • 8.4 APAC 239
      • 8.4.1 JAPAN 250
      • 8.4.2 CHINA 255
      • 8.4.3 INDIA 260
      • 8.4.4 REST OF APAC 266
    • 8.5 ROW 272
      • 8.5.1 BRAZIL 281
      • 8.5.2 REST OF LATAM 285
      • 8.5.3 MIDDLE EAST & AFRICA 290

    9 COMPETITIVE LANDSCAPE 295

    • 9.1 INTRODUCTION 295
    • 9.2 EXPANSION 296
    • 9.3 AGREEMENTS AND PARTNERSHIPS 298
    • 9.4 ACQUISITION 301
    • 9.5 PRODUCT APPROVAL AND LAUNCH 302
    • 9.6 OTHERS 303

    10 MAJOR COMPANIES 306

    • 10.1 CELESTICA INC. 306
      • 10.1.1 OVERVIEW 306
      • 10.1.2 FINANCIALS 307
      • 10.1.3 PRODUCT PORTFOLIO 309
      • 10.1.4 KEY DEVELOPMENTS 310
      • 10.1.5 BUSINESS STRATEGY 311
      • 10.1.6 SWOT ANALYSIS 312
    • 10.2 FLEX LTD. 313
      • 10.2.1 OVERVIEW 313
      • 10.2.2 FINANCIALS 314
      • 10.2.3 PRODUCT PORTFOLIO 317
      • 10.2.4 KEY DEVELOPMENTS 319
      • 10.2.5 BUSINESS STRATEGY 320
      • 10.2.6 SWOT ANALYSIS 321
    • 10.3 GERRESHIEMER AG 322
      • 10.3.1 OVERVIEW 322
      • 10.3.2 FINANCIALS 323
      • 10.3.3 PRODUCT PORTFOLIO 326
      • 10.3.4 KEY DEVELOPMENTS 326
      • 10.3.5 BUSINESS STRATEGY 327
      • 10.3.6 SWOT ANALYSIS 328
    • 10.4 INTEGER HOLDINGS CORPORATION 329
      • 10.4.1 OVERVIEW 329
      • 10.4.2 FINANCIALS 330
      • 10.4.3 PRODUCT PORTFOLIO 334
      • 10.4.4 KEY DEVELOPMENTS 335
      • 10.4.5 BUSINESS STRATEGY 336
      • 10.4.6 SWOT ANALYSIS 337
    • 10.5 JABIL INC. 338
      • 10.5.1 OVERVIEW 338
      • 10.5.2 FINANCIALS 339
      • 10.5.3 PRODUCT PORTFOLIO 342
      • 10.5.4 KEY DEVELOPMENTS 343
      • 10.5.5 BUSINESS STRATEGY 344
      • 10.5.6 SWOT ANALYSIS 345
    • 10.6 MOLEX, LLC 346
      • 10.6.1 OVERVIEW 346
      • 10.6.2 FINANCIALS 347
      • 10.6.3 PRODUCT PORTFOLIO 347
      • 10.6.4 KEY DEVELOPMENTS 348
      • 10.6.5 BUSINESS STRATEGY 351
      • 10.6.6 SWOT ANALYSIS 352
    • 10.7 PLEXUS CORP. 353
      • 10.7.1 OVERVIEW 353
      • 10.7.2 FINANCIALS 354
      • 10.7.3 PRODUCT PORTFOLIO 357
      • 10.7.4 KEY DEVELOPMENTS 358
      • 10.7.5 BUSINESS STRATEGY 359
      • 10.7.6 SWOT ANALYSIS 360
    • 10.8 SANMINA CORPORATION 361
      • 10.8.1 OVERVIEW 361
      • 10.8.2 FINANCIALS 362
      • 10.8.3 PRODUCT PORTFOLIO 366
      • 10.8.4 KEY DEVELOPMENTS 367
      • 10.8.5 BUSINESS STRATEGY 368
      • 10.8.6 SWOT ANALYSIS 369
    • 10.9 TECOMET, INC. 370
      • 10.9.1 OVERVIEW 370
      • 10.9.2 FINANCIALS 370
      • 10.9.3 PRODUCT PORTFOLIO 371
      • 10.9.4 KEY DEVELOPMENTS 372
      • 10.9.5 BUSINESS STRATEGY 372
      • 10.9.6 SWOT ANALYSIS 373
    • 10.10 WEST PHARMACEUTICAL SERVICES 374
      • 10.10.1 OVERVIEW 374
      • 10.10.2 FINANCIALS 375
      • 10.10.3 PRODUCT PORTFOLIO 378
      • 10.10.4 KEY DEVELOPMENTS 379
      • 10.10.5 BUSINESS STRATEGY 379

    Summary:
    Get latest Market Research Reports on Medical Device Contract Manufacturing. Industry analysis & Market Report on Medical Device Contract Manufacturing is a syndicated market report, published as Medical Device Contract Manufacturing Global Market - Forecast to 2026. It is complete Research Study and Industry Analysis of Medical Device Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,950.00
    $6,750.00
    $9,000.00
    3,945.15
    5,379.75
    7,173.00
    4,598.55
    6,270.75
    8,361.00
    758,488.50
    1,034,302.50
    1,379,070.00
    413,028.00
    563,220.00
    750,960.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report